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Synergistic Association of Genetic Variants
with Environmental Risk Factors in Susceptibility
to Essential Hypertension
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Grac¸a Guerra,1,2 Mariana Rodrigues,1 Eva Henriques,1 So´nia Freitas,1 Sofia Borges,1
De´cio Pereira,1 Anto´nio Brehm,2 and Roberto Palma dos Reis3
Aims: Essential hypertension (EH) is a disease in which both environment and genes have an important role.
This study was designed to identify the interaction model between genetic variants and environmental risk
factors that most highly potentiates EH development.
Methods: We performed a case–control study with 1641 participants (mean age 50.6– 8.1 years), specifically
848 patients with EH and 793 controls, adjusted for gender and age. Traditional risk factors, biochemical and
genetic parameters, including the genotypic discrimination of 14 genetic variants previously associated with
EH, were investigated. Multifactorial dimensionality reduction (MDR) software was used to analyze gene–
environment interactions. Validation was performed using logistic regression analysis with environmental risk
factors, significant genetic variants, and the best MDR model.
Results: The best model indicates that the interactions among the ADD1 rs4961 640T allele, diabetes, and
obesity (body mass index ‡30) increase approximately four-fold the risk of EH (odds ratio= 3.725; 95%
confidence interval: 2.945–4.711; p< 0.0001).
Conclusion: This work showed that the interaction between the ADD1 rs4961 variant, obesity, and the presence
of diabetes increased the susceptibility to EH four-fold. In these circumstances, lifestyle adjustment and
diabetes control should be intensified in patients who carry the ADD1 variant.
Keywords: genes, ADD1, environmental risk factors, obesity, MDR software, diabetes
Introduction
Essential hypertension (EH) is a complex and multi-factorial disease resulting from multiple environmental
and genetic factors (Carretero and Oparil, 2000; Kunesˇ and
Zicha, 2009; Joseph et al., 2013).
Both clinical and experimental studies have already iden-
tified plausible mechanisms underlying the development of
EH: increased activity of the sympathetic nervous system,
overactivity of the renin–angiotensin aldosterone system,
dysfunction of the vascular endothelium, thrombogenesis,
and impairment of the pressure-natriuresis mechanism lead-
ing to salt retention and elevated peripheral resistance, among
others (Oparil et al., 2003). All these systems are under strict
genetic control, and this is the cause that some individuals are
more susceptible to EH than others.
The majority of currently available knowledge has greatly
benefited by mapping the genes responsible for Mendelian
forms of hyper- and hypotension (Lifton et al., 2001) and
studying rodent models with various blood pressure (BP)
affecting phenotypes (Okamoto and Aoki, 1963; Cowley,
2006). These association studies have successfully identified
multiple interacting molecular pathways that are involved
in the determination of a subject’s BP. Consequently, genes
coding for the components of these molecular pathways have
been targeted for the identification of genetic variations affect-
ing interindividual differences in BP levels (Mein et al., 2004; Ji
et al., 2008). However, results of a large number of association
studies conducted with BP traits have been inconsistent.
Genome-wide association studies (GWAS) have emerged as
a novel alternative to explore simultaneously a large number
of genomic loci for associations with a phenotypic trait. This
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method has shown a great promise in determining common
polymorphisms responsible for several complex phenotypes
like diabetes, stroke, and coronary artery disease (Altshuler
et al., 2008). However, GWAS have not produced clear results
in respect of hypertension-associated gene polymorphisms
(Wellcome Trust Case Control Consortium, 2007; Levy et al.,
2007; Ehret et al., 2008). Although it has identified numerous
loci associated with BP traits (Levy et al., 2009), they only
explain a small proportion of interindividual BP variability.
The 29 loci identified by GWAS and reported by the Interna-
tional Consortium of Blood Pressure accounts for about 1% of
BP variation in the general population (Ehret et al., 2011).
Knowing the universal nature of epistasis in determining
susceptibility to complex disease, one possible way to ap-
proach these complex conditions is to examine the joint im-
pact of multiple genes involved in particular cellular or
physiological pathways along with several environmental
risk factors underlining it. Moreover, many clinical and ex-
perimental studies have bypassed important environmental
factors that can affect BP development and progression
(Zuoguang et al., 2013).
In these circumstances, in complex diseases, like EH, more
than to evaluate the polymorphisms one by one, it is impor-
tant to evaluate several polymorphisms together with envi-
ronmental factors.
Objective
The goal of the current study is to evaluate the best inter-
action model between 14 single nucleotide polymorphisms
(SNPs) associated to EH and several environmental risk
factors, in predicting the risk of EH in the population of
Madeira Island (Portugal).
Methods
Study population
All subjects participating in the present study were se-
lected from the Internal, General, and Familiar Medicine
from our Hospital.
This study received approval from the ethics committee of
the Funchal Hospital Center and was performed in confor-
mity with the guidelines outlined in the Declaration of Hel-
sinki statement. Written informed consent was obtained from
each participant, including explicit permission for the DNA
analyses and the collection of relevant clinical data.
Study design
A case–control study was performed with a cohort of 1641
individuals (50.6– 8.1 years; 49.9% male), namely 848 pa-
tients diagnosed with EH (mean age 50.8– 8.1; 51.8% male)
and 793 normotensive controls (mean age of 50.3– 8.2; 47.9%
male). Cases and controls were matched for sex and age.
EH was considered when patients, at the entry into this
study, were already diagnosed and/or had been on antihy-
pertensive medication for more than 3 months or newly di-
agnosed hypertensives with systolic blood pressure (SBP)/
diastolic blood pressure (DBP) ‡140/90 mmHg measured on
at least three occasions (European Society of Hypertension–
European Society of Cardiology Guidelines Committee,
2003). The normotensive controls had never been treated
with antihypertensive medication and presented a SBP/DBP
<140/90 mmHg.
BP was measured after 10 min of resting in the right arm,
using a standard Welch Allyn sphygmomanometer (phases I
through V). The average of three readings taken 2 min apart
was recorded (European Society of Hypertension–European
Society of Cardiology Guidelines Committee, 2003).
Data collection
Data recorded from each subject comprised demographic,
clinical profile, and traditional risk factors (gender, age, body
mass index [BMI], sedentary lifestyle, alcohol and smoking
habits, and diabetes).
BMI was defined as body mass divided by the square of the
body height, universally expressed in units of kg/m2, with
obesity defined as a BMI ‡30 (National Institutes of Health,
National Heart, Lung, and Blood Institute North American
Association for the Study of Obesity, 2000). Sedentary life-
style was considered when individuals practiced <150 min/
week of moderate activity or 75 min of vigorous activity)
(The Department of Health, Government of Australia, 2014).
Alcohol consumption was considered as a risk factor when
individuals consumed 70 g of alcohol per week for more than
1 year. Moreover, individuals who smoked ‡70 cigarettes
per week for more than 1 year were defined as ‘‘smokers’’
( Ji et al., 2013).
Subjects were classified as being diabetic when taking oral
antidiabetic medication or insulin or if their fasting plasma
glucose was higher than 7.0 mmol/L or 126 mg/dL (Expert
Committee on the Diagnosis and Classification of Diabetes
Mellitus, 2003).
Biochemical analysis
Blood samples were extracted after 14–16 h fasting. Bio-
chemical analyses were performed in the Central Laboratory
of the Hospital, according to standard techniques. To deter-
mine total cholesterol, high-density lipoprotein (HDL), low-
density lipoprotein, triglycerides, and glucose, blood samples
were placed in dry tubes, centrifuged half an hour later at
3500 g and subsequently quantified by an enzymatic tech-
nique using a ‘‘AU 5400’’ (Beckman Coulter) auto analyzer.
Biochemical markers such as lipoprotein-a, apolipoprotein B,
and high-sensitivity C-reactive protein (hs-CRP) were quantified
by immunoturbidimetry using an AU 5400 (Beckman Coulter)
automatic system. To measure fibrinogen, samples were placed
in a tube containing sodium citrate, and measurements were
taken with an ACL TOP 700 automatic analyzer.
SNP selection
SNPs were selected either from GWAS or candidate gene
association studies for loci biologically plausible to EH or
BP, specifically: ACE rs4340, ACE rs4343, AT1R rs5186, AGT
rs699, AGT rs4762, ADD1 rs4961, CYP11B2 rs1799998,
CYP17A1 rs11191548, ADRb1 rs1801253, ADRb2 rs1042713,
GNb3 rs5443, AT2B1 rs2681472, SLC4A2 rs2303934, and
SCNN1G rs5718.
Entering criteria included genes with a minor allele fre-
quency (MAF) >5%. Genes in Hardy–Weinberg disequilibrium
( p<0.0036, after Bonferroni correction) were automatically
excluded.
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Genetic analyses
Genetic analyses were done at the Human Genetics La-
boratory of the University of Madeira. Genomic DNA was
extracted from 80 mL of peripheral blood using a standard
phenol–chloroform method. A TaqMan allelic discrimination
assay for genotyping was performed using labeled probes and
primers pre-established by the supplier (TaqMan SNP Gen-
otyping Assays; Applied Biosystems).
Quality check of TaqMan genotyping technique was main-
tained by the inclusion of one nontemplate control in each plate
of 96 wells. Also, all SNP TaqMan assays had blind duplicates
accounting for 20% of all samples. Some SNP genotypes were
randomly confirmed by conventional direct DNA sequencing,
as 10–15% of all samples were reamplified for sequencing.
All reactions were done on an Applied Biosystems 7300 Real-
Time PCR System and genotypes were determined using the
7300 System SDS Software (Applied Biosystems, Foster City,
CA) without any prior knowledge of individual’s clinical data.
Statistical analyses
Genotypic frequencies were determined from observed
counts and compared by Chi-square analysis. Representative
samples were judged by comparing the genetic polymor-
phism frequency and Hardy–Weinberg equilibrium was tes-
ted at each locus on a contingency table of observed versus
predicted genotype using the Chi-squared test.
Continuous and categorical variables were compared between
the two groups by the unpaired Student’s t-test, Mann–Whitney,
and the Chi-squared test when appropriate. A two-tailed p value
of <5% was considered statistically significant, whereas a value
of Pb (PBonferroni divided by total number of comparisons) was
considered significant after the Bonferroni correction.
Five statistical genetic models were tested, namely domi-
nant, recessive, additive, multiplicative, and codominant.
The relative risk factor was evaluated using odds ratio (OR)
and 95% confidence interval (CI) for each model.
Interactions between variants significantly associated with
EH and five environmental risk factors for EH (sedentary
lifestyle, BMI, diabetes, smoking, and alcohol habits) were
analyzed by using multifactorial dimensionality reduction
(MDR) 3.0.2 software (Guy et al., 2010; Yang et al., 2015).
The best combination pattern was searched on the principle
that both cross-validation consistency and test balance ac-
curacy were maximized to evaluate the interaction of the
genetic polymorphism with each other and with the five en-
vironmental risk factors, in relation to EH.
To test the validity of MDR method, we further conducted
a classical logistic regression analysis that included the five
environmental risk factors and the best MDR model.
Statistical analyses were performed using the Statistical
Package for the Social Sciences Software version 19.0 (IBM,
Armonk, NY).
Results
Characteristics of the population
Baseline characteristics of our population are listed in Table 1.
There were no significant differences between cases and con-
trols in terms of age and sex. When compared with controls,
patients with EH had higher alcohol consumption ( p=0.008),
BMI ( p<0.0001), obesity ( p<0.0001), diabetes ( p<0.0001),
SBP ( p<0.0001), DBP ( p<0.0001), and heart rate ( p<0.0001)
(Table 1). Controls had more smoking habits in relation to hy-
pertensive subjects, with statistical significance ( p<0.0001).
Biochemical analysis of the population is shown in Table 2.
Comparatively to controls, hypertensive patients had signifi-
cantly higher levels of hemoglobin ( p< 0.0001), leucocytes
(<0.0001), fibrinogen (<0.0001), glucose (<0.0001), triglyc-
erides (<0.0001), apolipoprotein B ( p< 0.0001), and hs-CRP
(<0.0001). On the other hand, HDL cholesterol showed higher
values in controls, with a p< 0.0001 (Table 2).
Genetic polymorphisms and EH risk
Risk prediction of 14 polymorphisms related to EH was
evaluated under five genetic models of inheritance. Table 3
shows the results obtained from the best genetic model for
each SNP. All variants were in Hardy–Weinberg equilibrium
(Table 3). However, SLC4A2 rs2303934 was excluded due its
low MAF (3.2) (Table 3). The remaining 13 genetic variants
were included for further analysis.
Only two showed a statistically significant increase in
EH risk ( p<0.05), namely, the ADD1 rs4961 variant in the
recessive model (OR= 2.379; 95% CI: 1.135–4.985; p= 0.018)
and the GNb3 rs5443 variant in the dominant model (OR=
1.275; 95% CI: 1.042–1.559; p=0.018) (Table 3). Additionally,
Table 1. Baseline Characteristics of the Population
Variables Total (n = 1641) Hypertensives (n = 848) Controls (n = 793) p Value
Age, years 50.6 – 8.1 50.8 – 8.1 50.3– 8.2 0.212
Male sex, n (%) 819 (49.9) 439 (51.8) 380 (47.9) 0.119
Sedentary life, n (%) 887 (54.1) 476 (56.1) 411 (51.8) 0.080
Alcohol, n (%) 627 (38.2) 350 (41.3) 277 (26.6) 0.008
Smoking, n (%) 375 (22.9) 164 (19.3) 211 (26.6) <0.0001
BMI, kg/m2 27.7 – 4.9 29.2– 5.2 26.2 – 4 <0.0001
Obesity, n (%) 441 (26.9) 326 (38.4) 115 (14.5) <0.0001
Diabetes, n (%) 169 (10.3) 134 (15.8) 35 (4.4) <0.0001
SBP, mmHg 134.4 – 20.4 147.2– 18.9 120.7– 10.9 <0.0001
DBP, mmHg 84.5 – 12.1 91.1 – 11.7 77.4– 7.7 <0.0001
Heart rate, bpm 72.1 – 11.8 73.1 – 12.2 71– 11.2 <0.0001
Continuous variables are expressed by mean– standard deviation.
Statistically significant for p < 0.05.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; bpm, beats per minute.
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the ACE rs4343 was marginally significant being at the
threshold of significance ( p= 0.053) with an OR of 1.148 (95%
CI: 0.999–1.321) (Table 3).
Gene–environment interactions and the EH risk
MDR software was employed to analyze the interaction
between the three mentioned variants (ADD1 rs4961, GNB3
rs5443, and ACE rs4343) and five nongenetic risk factors for
EH (sedentary lifestyle, obesity, diabetes, smoking, and alco-
hol habits) (Table 4). The best association model included
diabetes, obesity, and ADD1 rs4961 polymorphism, which
showed a maximal testing accuracy of 0.638 and a cross-
validation consistency of 10 out of 10 (Table 4). These results
indicate that ADD1 rs4961 interacts with diabetes and obesity
in a synergistic way with a 3.725-fold greater risk of EH
(Table 4). Consequently this model was chosen as the overall
best MDR model, which was significant at a level of 0.0002,
indicating overall a better performance by 2 out of 10,000
permutations and was thus unlikely under the null hypothesis
of null association.
To test the validity of the MDR method, we further con-
ducted a logistic regression analysis that combined the two
individually significant polymorphisms rs4961 and rs4343, the
confounding factors (sedentary lifestyle, smoking, and alcohol
habits), and the best interaction MDR model (diabetes, obesity,
and ADD1 rs4961) (Table 5). The results confirmed that the
interaction between diabetes, obesity, and ADD1 rs4961
showed a significant association of 10-fold increased EH risk
(95% CI: 2.336–43184; p= 0.002) (Table 5). Furthermore,
sedentary lifestyle and alcohol presented a risk for EH of 1.229
and 1.390, respectively, with statistical significance ( p< 0.05).
Table 2. Biochemical Characteristics of the Population
Variables Total (n= 1641) Hypertensives (n = 848) Controls (n = 793) p Value
Hemoglobin, g/dL 14.3 (9.6–18.2) 14.4 (9.6–18.2) 14.2 (10.1–17.6) <0.0001
Platelets, 103/mL 229 (23–664) 233 (23–664) 227 (65–544) 0.206
Leucocytes, 103/mL 6.4 (2.1–18) 6.6 (2.9–18) 6.2 (2.1–16.6) <0.0001
Fibrinogen, mg/dL 362 (179.2–874) 371 (179.2–874) 355.3 (224–688) <0.0001
Glucose, mg/dL 95 (66–364) 98 (70–360) 93 (66–364) <0.0001
Lipoprotein (a), mg/dL 16.3 (0.6–236) 16.6 (0.6–236) 16.2 (0.8–198.2) 0.730
Cholesterol, mg/dL 207 (107–370) 208.5 (115–344) 206 (107–370) 0.193
HDL, mg/dL 48 (17.2–111.7) 46.9 (17.2–103) 49 (20.8–111.7) <0.0001
LDL, mg/dL 131 (37.7–269) 131 (37.7–269) 131 (42–260) 0.944
Triglycerides, mg/dL 110 (21–1098) 119 (29–1098) 99 (21–688) <0.0001
Apolipoprotein B, mg/dL 104 (3.9–232) 106.6 (5.1–205) 99.7 (3.9–232) <0.0001
hs-CRP, mg/dL 0.22 (0.01–18.51) 0.25 (0.02–13.1) 0.19 (0.01–18.51) <0.0001
Biochemical variables are presented by median (minimum–maximum).
Statistically significant for p < 0.05.
HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein.
Table 3. Risk Prediction of Fourteen Polymorphisms Related to Essential Hypertension
in Our Population (n = 1641), Selected from the Best Genetic Model of Inheritance
Gene SNP Chr Position Cases Controls ORa (95% CI) p Value
MAF
(%)
p Value
HW
ACE I/D rs4340 17 61,565,892 65.7 62.8 1.137 (0.985–1.312)b 0.079b 34.3 0.110
ACE 2350 A/G rs4343 17 63,488,670 58.4 55.1 1.148 (0.999–1.321)c 0.053c 41.6 0.721
AGT T/M (T174M) rs4762 1 230,710,231 30.7 29.6 1.198 (0.941–1.525)d 0.143d 30.7 0.790
AGT M/T (M235T) rs699 1 230,710,048 43.5 42.1 1.117 (0.909–1.373)d 0.291d 43.5 0.766
AT1R A/C rs5186 3 148,742,201 24.8 24.0 1.094 (0.900–1.331)d 0.366d 24.8 0.097
CYP11B2 C/T rs1799998 8 142,918,184 55.5 55.5 0.927 (0.724–1.187)d 0.548d 44.5 0.823
CYP17A1 T/C rs11191548 10 103,086,421 10.7 10.3 1.150 (0.473–2.794)e 0.757e 10.7 0.629
ADD1 G/T rs4961 4 2,904,980 16.3 14.7 2.379 (1.135–4.985)f 0.018f 16.3 0.550
GNb3 C/T rs5443 12 6,845,711 40.7 38.3 1.275 (1.042–1.559)d 0.018d 40.7 0.140
ADRb1 R/G (R389G) rs1801253 10 114,045,297 30.7 29.6 1.089 (0.897–1.322)d 0.387d 30.7 0.213
ADRb2 R/G (R16G) rs1042713 5 148,826,877 55.8 57.8 0.925 (0.805–1.062)b 0.268b 44.2 0.716
SCNN1G A/G rs5718 16 23,182,544 56.8 55.7 1.170 (0.926–1.478)d 0.187d 43.2 0.014
SLC4A2 C/T rs2303934 7 150,767,540 3.2 2.8 1.168 (0.769–1.775)d 0.467d 3.2 0.021
ATP2B1 A/G rs2681472 12 89,615,182 15.3 15.1 0.780 (0.433–1.405)f 0.407f 15.3 0.745
aOR from the best model.
bMultiplicative model.
cAdditive model.
dDominant model.
eCodominant model.
fRecessive model.
OR, odds ratio; SNP, single nucleotide polymorphism; Chr, chromosome; MAF, minor allele frequency; HW, Hardy–Weinberg using
p < 0.004 after Bonferroni correction; CI, confidence interval.
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Smoking appeared with a protective effect for EH (OR= 0.615
95% CI 0.485–0.780; p< 0.0001).
Because obesity appeared to be an important risk factor
for EH development in our MDR analysis, we have further
done a crossover analysis (Table 6) and a stratified analysis
(Table 7) to investigate whether the obesity or ADD1 rs4961
represented the greatest effect on the EH risk.
Results showed that both obesity and the TT genotype
of ADD1 rs4961 greatly increased the susceptibility to hy-
pertension, but obesity seems to have the major effect
(OR = 5.936 vs. OR= 2.638) (Table 6).
In the stratified analysis, results showed that on obese in-
dividuals, the ADD1 rs4961 TT genotype had no significant
association with EH ( p = 0.546). On the other hand, the TT
genotype showed a significant increase in EH risk in non-
obese individuals (OR = 2.648, 95% CI: 1.125–6.236;
p = 0.021), indicating that the risk for this polymorphism is
greater when the person is nonobese (Table 7). The effect of
obesity is much stronger than the existence of the ADD1
variant; however, an interaction between the two variables
synergistically increases the risk of EH.
Discussion
It is well established that both genetic and environmental
factors contribute to the regulation and maintenance of BP.
With the beginning of the human genome project and the
International HapMap Project, SNPs have become increas-
ingly prominent in studies of both multifactorial and multi-
genomic diseases (Kunesˇ and Zicha, 2009).
In the present work, there were three polymorphic variants,
which were significantly associated to EH individually—
rs4961, rs5443, and rs4343, this last on the threshold of
significance. ADD1 rs4961 was selected in the three-factor
model along with obesity and diabetes as the best association
model to predict EH. The four-factor model that included
obesity, diabetes, ADD1 rs4961, and ACE rs4343 was also
selected but had a slightly lower testing balanced accuracy
and a weak cross-validation consistency.
The ADD1 G614T polymorphism (rs4961) results in the
amino acid substitution of glycine by tryptophan (Gly460Trp),
which is reported to be associated with a salt-sensitive form
of hypertension. Cusi et al. (1997) found significant linkage
of the alpha-adducin locus to EH ( p = 0.0003) and greater
sensitivity to changes in sodium balance among patients
with the mutant allele, suggesting that alpha-adducin is as-
sociated with a salt-sensitive form of EH (Cusi et al., 1997).
However, epidemiological studies have shown that the
contribution of ADD1 Gly460Trp mutation to hypertension
varies among different ethnic groups. A positive association
of this genetic variant with EH has been confirmed in some
studies (Tamaki et al., 1998; Barlassina et al., 2000; Ju et al.,
2003; Li et al., 2012), but not in others (Larson et al., 2000;
Niu et al., 2010).
As far as we know, this study is the first attempt to establish
the interaction between polymorphic variants associated with
EH and several environmental risk factors, in the suscepti-
bility to develop EH, in a cohort of Southern European origin.
The interaction between ADD1 polymorphism and nonge-
netic risk factors, such as obesity and diabetes was identified
as the overall optimum synergistic model by using a prom-
ising data-mining analytical method, MDR. This method has
been successfully applied to detect high-order gene–gene and
gene–environment interaction (Guy et al., 2010).
Table 4. Best Models to Analyze Gene–Environment Interactions
by Multifactorial Dimensionality Reduction
Best model
Training
balanced
accuracy
Training
odds ratio
Training
p-value
Testing
balanced
accuracy
Testing
odds ratio
Testing
p-value
CV
consistency
Obesity 0.620 3.682 (2.855–4.748) <0.0001 0.620 3.682 (1.717–7.900) 0.0005 10/10
Diabetes; obesity 0.635 3.726 (2.936–4.728) <0.0001 0.635 3.726 (1.823–7.614) 0.0002 10/10
Diabetes; obesity;
ADD1a
0.638 3.725 (2.945–4.711) <0.0001 0.638 3.725 (1.842–7.535) 0.0002 10/10
Diabetes; obesity;
smoking; ADD1
0.639 3.952 (3.105–5.030) <0.0001 0.628 3.467 (1.704–7.055) 0.0004 6/10
aOverall best combination model with highest training balanced accuracy, highest testing accuracy, and best CV consistency.
CV, cross validation.
Table 5. Logistic Regression Analysis with Multifactorial Dimensionality Reduction
Best Model and Confounding Variables
Variables B SE Wald df Odds ratio (95% CI) p Value
Smoking -0.487 0.121 16.105 1 0.615 (0.485–0.780) <0.0001
Sedentary life 0.206 0.101 4.190 1 1.229 (1.009–1.497) 0.041
Alcohol 0.329 0.104 9.957 1 1.390 (1.133–1.705) 0.002
ADD1 (GT +TT) ·Diabetes
(Yes) ·Obesity (Yes)
2.307 0.744 9.611 1 10.044 (2.336–43.184) 0.002
Constant -0.081 0.086 0.891 1 0.922 0.345
Forward Wald method (SPSS vs. 19.0) with all variables staying in the model.
Statistically significant for p < 0.05.
B, beta coefficient; SE, standard error; df, degrees of freedom.
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Such best interaction cannot be overlooked because in
obesity there are a variety of endocrine, genetic, and meta-
bolic mechanisms linked to each other that include insulin
resistance, hyperinsulinemia, increased serum aldosterone
levels, salt sensitivity, and expanded plasma volume with
increased peripheral vascular resistance, which can lead to
EH. Since BMI represents the internal metabolic and physi-
ological environment that plays a key role in the development
of high BP (Feng et al., 2012), and ADD1 rs4961 is one of the
most important targets for salt sensitivity and expanded
plasma volume, it is not surprising that their interaction may
play an important role in the susceptibility to hypertension.
However, the exact pathophysiological mechanisms that
contribute to this association require further study.
On the other hand, it is now established that insulin re-
sistance, which predicts type 2 diabetes, also has a role in the
development of hypertension (Sowers, 2004; Conen et al.,
2007). Indeed, hypertension and diabetes substantially share
common pathways, such as obesity, inflammation, oxidative
stress, and insulin resistance.
In our case–control study, diabetes, obesity, alcohol con-
sumption, and ADD1 TT genotype were confirmed as inde-
pendent risk factors for EH by multivariate logistic regression.
Curiously, smoking habits appear to be a protector factor. A
likely explanation of these apparent protective effects of
smoking on hypertension might be related to the fact that
physicians had likely advised their hypertensive patients to
quit smoking, so that the proportion of smoking hypertensives
is lower than the proportion of nonsmoking ones.
Further research on gene–gene and gene–environment
interaction with well-designed studies containing large
sample size and multiple genetic polymorphisms and envi-
ronmental risk factors are needed to provide more precise
evidence for the issue.
Strength and limitations
One limitation of the study was that only 13 polymor-
phisms of relevant genes for EH were analyzed, and it is of
added interest to explore other candidate genes within dif-
ferent metabolic axes and other emerged from GWAS with
yet unknown pathophysiological mechanisms.
Other limitation to the approach is that MDR method
does not have a way to adjust for covariate effects, such as
age, gender, alcohol, and smoking status, an often neces-
sary step to obtain an unconfounded SNP interactions
outcome. For this reason, we used a second logistic re-
gression with the MDR best model adjusted for con-
founded variables and so we were able to confirm the
independence of this interaction.
A strength of our study was the specificity of our popu-
lation, which is supposed to be a genetically homogeneous
Southern European Caucasian population (Brehm et al.,
2003; Gonc¸alves et al., 2005). The use of genetically isolated
populations has been particularly valuable for mapping rare
recessive disorders, or more complex disorders due to a
relatively uniform genetic background of the populations
(Kristiansson et al., 2008). Some culturally and genetically
isolated populations have a more similar way of living,
eating habits, and natural environment that reduces envi-
ronmental variation ( Jorde and Wooding, 2004).
Conclusion
According to our findings, the evolution to EH may actu-
ally be affected by the interaction of ADD1 rs4961, obesity,
and type 2 diabetes in our population. In patients carrying this
polymorphism, involved in salt handling, it will be of utmost
importance the modification of lifestyle.
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